Comparative clinical and microbiological efficacy of mouthwashes containing 0.2% and 0.12% chlorhexidine

S K Rath, Munishwar Singh, S K Rath, Munishwar Singh

Abstract

Background: The main stay of primary and secondary prevention of periodontal diseases has been the control of supra gingival plaque. Acceptable plaque control by mechanical means is difficult to achieve by most individuals, so mouth rinses represent one form of attack on oral microbes and the malodor. Chlorhexidine (CHX) is a broad-spectrum antimicrobial agent known to cause damage to the cell membrane of microorganisms and at higher concentrations causes precipitation and coagulation of the proteins in the cytoplasm of the exposed microbes. The aim of this study is to evaluate and compare the efficacy of 0.12% and 0.2% concentration of CHX gluconate clinically as well as microbiologically.

Materials and methods: The single blind placebo controlled randomized study design comprising of 75 males with an age between 25 years and 50 years were selected from out-patient Department of Periodontics. The subjects were randomly divided into five groups. After baseline clinical and microbiological examination, the groups were subjected to mechanical plaque control with or without mouthwashes containing various concentrations of CHX and placebo. After 90 days the data pertaining to clinical and microbiological parameters were compared to the baseline data so as to compare the efficacy of different concentrations of mouthwashes.

Results: The results achieved with the use of 0.2% and 0.12% concentrations of CHX were comparable; taking into consideration of various clinical and microbiological parameters.

Conclusion: The study recommends the use of low concentration of (0.12%) CHX for better patient compliance with the optimum clinical results.

Keywords: Chemical plaque control; chlorhexidine; mouthwashes.

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Anaerobic chamber
Figure 2
Figure 2
Growth of colonies of BPB's (porphyromas) at baseline (Group C)
Figure 3
Figure 3
Post-treatment growth of colonies of BPB's (porphyromas) after 90 days (Group C)
Figure 4
Figure 4
Growth of colonies of BPB's (porphyromas) at baseline (Group D)
Figure 5
Figure 5
Post-treatment growth of colonies of BPB's (porphyromas) after 90 days (Group D)

References

    1. Loe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol. 1965;36:177–87.
    1. Hujoel P, Zina LG, Cunha-Cruz J, Lopez R. Historical perspectives on theories of periodontal disease etiology. Periodontol 2000. 2012;58:153–60.
    1. Lim KS, Kam PC. Chlorhexidine: Pharmacology and clinical applications. Anaesth Intensive Care. 2008;36:502–12.
    1. Veksler AE, Kayrouz GA, Newman MG. Reduction of salivary bacteria by pre-procedural rinses with chlorhexidine 0.12% J Periodontol. 1991;62:649–51.
    1. Berchier CE, Slot DE, Van der Weijden GA. The efficacy of 0.12% chlorhexidine mouthrinse compared with 0.2% on plaque accumulation and periodontal parameters: A systematic review. J Clin Periodontol. 2010;37:829–39.
    1. Southard SR, Drisko CL, Killoy WJ, Cobb CM, Tira DE. The effect of 2% chlorhexidine digluconate irrigation on clinical parameters and the level of Bacteroides gingivalis in periodontal pockets. J Periodontol. 1989;60:302–9.
    1. Segreto VA, Collins EM, Beiswanger BB, La Rosa M, Isaacs RL, Lang NP, et al. A comparison of mouthrinses containing two concentrations of chlorhexidine. J Periodont Res. 1986;21(Suppl):23–32.
    1. Jenkins S, Addy M, Newcombe RG. Dose response of chlorhexidine against plaque and comparison with triclosan. J Clin Periodontol. 1994;21:250–5.
    1. Greenstein G, Berman C, Jaffin R. Chlorhexidine. An adjunct to periodontal therapy. J Periodontol. 1986;57:370–7.
    1. Cancro LP, Klein K, Picozzi A. Dose response of chlorhexidine gluconate in a model in vivo plaque system. J Dent Res. 1973;52:223–6.
    1. Cancro LP, Paulovic DB, Bolton S, Picozzi A. Dose response of chlorhexidine gluconate in a model in vivo plaque system. J Dent Res. 1974;53:765–6.
    1. Flötra L, Gjermo P, Rölla G, Waerhaug J. Side effects of chlorhexidine mouth washes. Scand J Dent Res. 1971;79:119–25.
    1. Emilson CG, Eriksen TH, Heyden G, Magnusson BC. Uptake of chlorhexidine to hydroxylapatite. J Periodont Res. 1973;8:17–21.
    1. Mendieta C, Vallcorba N, Binney A, Addy M. Comparison of 2 chlorhexidine mouthwashes on plaque regrowth in vivo and dietary staining in vitro. J Clin Periodontol. 1994;21:296–300.
    1. Japoni A, Vasin A, Noushadi S, Kiany F, Japoni S, Alborzi A. Antibacterial susceptibility patterns of Porphyromonas gingivalis isolated from chronic periodontitis patients. Med Oral Patol Oral Cir Bucal. 2011;16:e1031–5.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する